Delivery Order SPE2DE21D7009-SPE2D626F45R3
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,834.00 on November 28, 2025, for pain management medical devices and services. The delivery order, which is fixed price with economic price adjustment provisions, has an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. This award represents a child delivery order issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $43,709.82 fixed-price delivery order with economic price adjustment on December 15, 2025, for pain management medical devices and related services. The delivery order, which is part of the larger SPE2DE indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical branch valued at $83.1 million through August 2026, carries no small business set-aside designation. Work...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F45R3Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a fixed-price delivery order valued at $6,176.10 on December 15, 2025, for pain management medical devices and services. The delivery order, which is a child contract under a larger indefinite delivery vehicle, will be performed in Valencia, California, and is scheduled for completion by December 29, 2025. This award carries no small business set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity serving the Department of Defense and Department of Veterans Affairs. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies for non-opioid pain management, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices designed to serve military treatment facilities and VA medical centers. This delivery order represents a continuation of the company's strategic role as a critical supplier under the larger SPE2DE indefinite delivery contract with DLA Troop Support Medical, valued at $83.1 million through August 2026. The fixed-price structure with economic price adjustment provisions allows for responsive procurement of specialized pain management technologies to support active-duty service members and veterans managing chronic pain from traumatic injuries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 12/14/25 |